Filter

21 - 30 of 357 Results

  • Where To Start To Build Vaccine Confidence

    From Drew Altman

    In this Axios column Drew Altman writes about the recent attention to Republican vaccine resisters. “Republicans and rural Americans are among the most resistant vaccine holdouts and some strategies are emerging to reach them." But “far from all Republicans are resisters” and “the bigger and quicker payoff will come from prioritizing the more moveable group of 'wait and see' Americans.”

  • In his latest column, KFF’s President and CEO Drew Altman discusses how the low levels of trust in the CDC and FDA today seen in KFF’s recent survey findings present a danger should the country face another epidemic.

    The Sad State of Trust in the CDC and FDA

    From Drew Altman

    In his latest column, KFF’s President and CEO Drew Altman discusses how the low levels of trust in the CDC and FDA today seen in KFF’s recent survey findings present a danger should the country face another epidemic.

  • Vaccine Misinformation Spreads as Children Head Back to School — The Monitor

    Feature

    This edition highlights vaccine hesitancy and misinformation around MMR (measles, mumps, and rubella) vaccines as children return to school and measles cases resurge in parts of the U.S. It also examines emerging narratives around COVID-19 vaccine misinformation following the FDA approval of COVID-19 boosters and false claims linking mpox to the vaccines.

  • Anti-Vaccine Disinformation Campaign, Sunscreen Myths, and Counterfeit Ozempic on Social Media — The Monitor

    Feature

    This edition focuses on intentionally false or misleading information online and its potential impact on public trust in health care. We share a recent report that exposed a covert U.S. military social media disinformation campaign in the Philippines that may have undermined public confidence in vaccines. We also examine how false claims about sunscreen and non-FDA-approved "miracle cures" may be discouraging people from taking important preventative measures and seeking legitimate medical treatment. Finally, we explore the rise of counterfeit diabetes and weight-loss drugs like Ozempic and the potential impact on trust in the pharmaceutical supply chain.

  • Supreme Court Cases on Content Moderation and Mifepristone Access — The Monitor

    Feature

    This issue of the Monitor focuses on recent Supreme Court decisions impacting health misinformation. We examine cases balancing free speech and platform regulation, the Court’s ruling on mifepristone access and public perceptions of social media moderation. We also explore COVID-19 narratives after Dr. Fauci’s congressional testimony and AI developments in predicting misinformation trends during pandemics.

  • Raw Milk Myths, Vaccine Falsehoods, and Reproductive Health Narratives – The Monitor

    Feature

    This first edition of the Health Misinformation Monitor explores misinformation about raw milk amid bird flu outbreaks on dairy farms, false vaccine narratives that continue to spread, and legal challenges against abortion pill reversal claims. Additionally, a growing number of states have required public schools to show fetal development videos that some have called biased and inaccurate. This Monitor report also provides a snapshot of new KFF misinformation polling on TikTok and discusses the early challenges faced by The World Health Organization’s new AI tool SARAH in providing accurate answers to health questions.

  • KFF Health Misinformation Tracking Poll: Health and Election Issues on TikTok

    Poll Finding

    KFF's Health Misinformation Tracking Poll shows that most adults who use the social media app TikTok report seeing health-related information or advice on the app. While fewer than half of users say they trust health information they see on the app, younger, Black and Hispanic users report higher levels of trust.

  • Year in Review: 10 Health Policy Issues for 2023

    Fact Sheet

    This fact sheet offers a look back at 10 issues that KFF tracked closely during 2023 in its polling, policy analysis and journalism, including summaries of major findings and news stories.